Department of Infectious Diseases Details Findings in COVID-19 (Safety and efficacy of tocilizumab in the treatment of severe acute respiratory syndrome coronavirus-2 pneumonia: A retrospective cohort study)

Source :: Medical Letter on the CDC & FDA. August 16, 2020, 413
Publication Year :: 2020
Abstract: 2020 AUG 16 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Researchers detail new data in Coronavirus - COVID-19. According to [...]

Subjects :: Severe acute respiratory syndrome -- Research -- Drug therapy
Coronaviruses -- Analysis -- Health aspects -- Research
Tocilizumab -- Research
Communicable diseases -- Drug therapy -- Research
Pneumonia -- Drug therapy -- Research
Medical research -- Analysis -- Health aspects
COVID-19 -- Drug therapy -- Research
Business
Health
Health care industry

Tools